Alpha PSMA \u0026 New Targets in Prostate Cancer | ProsTIC/PCF Global Webinar

(1:28:54)

PSMA-targeted alpha emitter 225Ac-J591 for mCRPC

(7:14)

Just the Beginning: What's Next for Radiotheranostics in Prostate Cancer?

(14:39)

ProsTIC24 - Marwa Rahimi: Alpha and Beyond: Nuclear Frontier in PSMA Theranostics (Preclinical)

(12:24)

Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer

(46:31)

PSMA Therapy | Dr Ishita B Sen | Nuclear Medicine Therapy | FMRI

(9:17)

Targeted Alpha Therapies in Prostate Cancer

(17:9)

Prostate Cancer Treatment Advancement: PSMA Alpha-PET DoubLET Platform

(2:27)

PSMA: Current State of the Art and Future Vision

(12:41)

PSMA-TRT, 225Ac-J591 and 177Lu-PSMA I\u0026T in mCRPC

(3:7)

Imaging Alternatives For PSMA Negative #ProstateCancer Patients | #MarkScholzMD #AlexScholz #PCRI

(20:21)

Targeted Alpha Particle Therapy: Imaging, Dosimetry and Radiation Protection

(27:42)

Theranostics in Prostate Cancer: New Therapies for the 21st and 22nd Centuries

(35:3)

Advances in PSMA-targeted therapy for prostate cancer

(1:36)

Radionuclide conjugates 225Ac-J591 and 177Lu-PSMA-I\u0026T for mCRPC

(3:30)

Appropriate Use of PSMA PET in Clinical Practice

(16:28)

2024 Update | Lu-177 (Pluvicto), Actinium \u0026 New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz

(57:58)

Comparing Alpha and Beta Emitters, and Looking to the Future of Advanced Prostate Cancer Care

(7:45)

How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI

(14:9)

2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRI

(32:5)